Medical Disclaimer

Regulatory status of peptides

A small number of peptides covered on this site are FDA-approved prescription medications (for example semaglutide and tirzepatide for weight loss and type 2 diabetes, oxytocin in labour and delivery, sermorelin in adult growth hormone deficiency).

Most peptides covered are not approved for human use in the United States, the United Kingdom, the European Union, Australia, or most other jurisdictions. Some are listed on the World Anti-Doping Agency Prohibited List. Many are sold only as research chemicals labelled "not for human consumption". Legality and prescribing status vary by country and change over time. Always check current local regulations.

Dosage information

Dosage ranges shown on Peptide Reference are summarised from published clinical trials, FDA labels, and research protocols. They are presented for academic reference. They are not personalised dosing recommendations, and they do not account for individual factors such as body weight, comorbidities, concurrent medications, allergies, pregnancy, organ function, or formulation purity.

AI-generated summaries

Plain-English summaries of research papers on this site are generated with the help of AI tools. These summaries can contain inaccuracies, oversimplifications, or omissions. Treat every AI summary as a pointer to the original paper, never as a substitute for it. Every summary on the site links to its source on PubMed.

No doctor–patient relationship

Reading this site, contacting us, or any other interaction with Peptide Reference does not create a doctor–patient relationship of any kind. We do not provide medical consultations, prescriptions, or personalised health advice.

Affiliate links

Some links on the site are affiliate links to research-grade peptide suppliers and to ancillary supplies on Amazon. We may earn a commission on qualifying purchases. Affiliate revenue does not influence the editorial content of peptide profiles. See our editorial standards for full disclosure.